Inovio Pharmaceuticals, Inc.
Cancer vaccines and methods of treatment using the same
Last updated:
Abstract:
The invention provides a vaccine comprising a nucleic acid molecule that encodes a dog telomerase reverse transcriptase (dTERT) antigen, as well as methods of using the vaccine to induce an immune response against a TERT and to treat cancer in a mammal.
Status:
Grant
Type:
Utility
Filling date:
3 Feb 2017
Issue date:
18 May 2021